CIK 0001513525
- Non-accelerated filer
- Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800667150
- Phone
- +1 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 700 shares at $2.74 ($1,918)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 157,500 shares (grant or award)
- 4 Grant or award Director acquired 240,800 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 420,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Returned to the company Director returned 166,667 shares (to the company)
- 4 Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 1,000,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 250,000 shares (grant or award)
Page 3 of 7 · 123 filings